Cargando…
Possibility of exosome-based coronavirus disease 2019 vaccine
Coronavirus disease 2019 (COVID-19) is a global pandemic that can have a long-lasting impact on public health if not properly managed. Ongoing vaccine development trials involve classical molecular strategies based on inactivated or attenuated viruses, single peptides or viral vectors. However, ther...
Autores principales: | Yoo, Kwang Ho, Thapa, Nikita, Kim, Beom Joon, Lee, Jung Ok, Jang, You Na, Chwae, Yong Joon, Kim, Jaeyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630821/ https://www.ncbi.nlm.nih.gov/pubmed/34821373 http://dx.doi.org/10.3892/mmr.2021.12542 |
Ejemplares similares
-
Transforming growth factor-β family and stem cell-derived exosome therapeutic treatment in osteoarthritis (Review)
por: Yoo, Kwang Ho, et al.
Publicado: (2022) -
Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (Review)
por: Thapa, Nikita, et al.
Publicado: (2022) -
Dermal fibroblast cell‐derived exosomes for atopic dermatitis: In‐vitro test
por: Yoo, Kwangho, et al.
Publicado: (2023) -
Apoptotic cell-derived exosomes: messages from dying cells
por: Kakarla, Ramesh, et al.
Publicado: (2020) -
Exosomes derived from human dermal fibroblasts protect against UVB-induced skin photoaging
por: Park, A Yeon, et al.
Publicado: (2023)